GLP-1 Drug Market – North America Leads While Asia-Pacific Accelerates
North America leads the global GLP-1 drug market, contributing more than 50% of 2024 revenue. The region benefits from high diabetes prevalence, strong pharmaceutical investment, advanced healthcare systems, treatment awareness, and favorable reimbursement arrangements.marketresearchfuture The United States is the largest national market because of broad demand for diabetes and obesity care, a...
0 التعليقات 0 المشاركات 101 مشاهدة 0 معاينة